GlassScriptPhysician profile
Reid Culton
NPI 1215023791
$5,399.53
in general payments reported to CMS, 2019-2025
56 companies · $1,297 in 2025
The $1,297 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $375 · 2021: $757 · 2022: $432 · 2023: $955 · 2024: $1,023 · 2025: $1,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,276.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,275.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $676.52 | 2019-2025 | Tezspire, Lynparza, Bevespi Aerosphere |
| Merck Sharp & Dohme LLC | $642.66 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $375.93 | 2021-2025 | |
| Janssen Biotech, INC. | $237.89 | 2021-2025 | Balversa, Erleada, Akeega |
| Abbvie INC. | $215.53 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $175.02 | 2020-2025 | Alunbrig, Fruzaqla, Gattex |
| Lilly USA, LLC | $169.39 | 2021-2025 | Verzenio, Jaypirca, Retevmo |
| Pfizer INC. | $163.23 | 2020-2025 | |
| Astellas Pharma US INC | $160.65 | 2022-2025 | Xtandi, Vyloy |
| Sobi, INC | $157.50 | 2022-2023 | |
| Tactile Systems Technology INC | $148.49 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Celgene Corporation | $142.05 | 2019-2024 | Reblozyl |
| Incyte Corporation | $131.65 | 2019-2025 | Zynyz, Monjuvi, Jakafi |
| Amgen INC. | $118.02 | 2019-2021 | |
| Aveo Pharmaceuticals, INC. | $111.48 | 2022-2025 | Fotivda |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reid Culton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.